Quang A Le1. 1. Department of Pharmacy Administration and Practice, Western University of Health Sciences, 309 E. Second Street, Pomona, CA, 91766-1854, USA, qle@westernu.edu.
Abstract
PURPOSE: Probabilistic mapping of the health status instrument SF-12 onto the health utility instrument EuroQol-5 dimensions (EQ-5D)-3L using the UK-population-based scoring model showed encouraging results as compared to other mapping methods, although its predictive performance using the US-population-based EQ-5D scoring models has not been investigated. In addition, a new and improved US-population-based EQ-5D scoring method has recently been developed and suggested for use in applications that required US societal health state values. In this study, we assessed predictive performance of the probabilistic mapping approach using the US-population-based scoring models on EQ-5D utility scores based on SF-12 responses and compared the results with those of other mapping methods. METHODS: Using a sample of 19,678 adults from the 2003 Medical Expenditure Panel Survey, we evaluated the predictive performance of probabilistic mapping using Bayesian networks, response mapping using multinomial logistic regression, ordinary least squares, and censored least absolute deviations models by implementing a fivefold cross-validation method. The EQ-5D utility scores were generated using two US-population-based models: D1 and MM-OC. RESULTS: Overall, the probabilistic mapping approach using Bayesian networks consistently outperformed other mapping methods with mean squared errors (MSE) of 0.007 and 0.007, mean absolute errors (MAE) of 0.057 and 0.039, and overall R (2) of 0.773 and 0.770 for the US-population-based EQ-5D scoring D1 and MM-OC models, respectively. CONCLUSION: The probabilistic mapping approach can be useful to estimate EQ-5D utility scores from SF-12 responses with better predictive measures in terms of MSE, MAE, and R (2) than other common mapping methods.
PURPOSE: Probabilistic mapping of the health status instrument SF-12 onto the health utility instrument EuroQol-5 dimensions (EQ-5D)-3L using the UK-population-based scoring model showed encouraging results as compared to other mapping methods, although its predictive performance using the US-population-based EQ-5D scoring models has not been investigated. In addition, a new and improved US-population-based EQ-5D scoring method has recently been developed and suggested for use in applications that required US societal health state values. In this study, we assessed predictive performance of the probabilistic mapping approach using the US-population-based scoring models on EQ-5D utility scores based on SF-12 responses and compared the results with those of other mapping methods. METHODS: Using a sample of 19,678 adults from the 2003 Medical Expenditure Panel Survey, we evaluated the predictive performance of probabilistic mapping using Bayesian networks, response mapping using multinomial logistic regression, ordinary least squares, and censored least absolute deviations models by implementing a fivefold cross-validation method. The EQ-5D utility scores were generated using two US-population-based models: D1 and MM-OC. RESULTS: Overall, the probabilistic mapping approach using Bayesian networks consistently outperformed other mapping methods with mean squared errors (MSE) of 0.007 and 0.007, mean absolute errors (MAE) of 0.057 and 0.039, and overall R (2) of 0.773 and 0.770 for the US-population-based EQ-5D scoring D1 and MM-OC models, respectively. CONCLUSION: The probabilistic mapping approach can be useful to estimate EQ-5D utility scores from SF-12 responses with better predictive measures in terms of MSE, MAE, and R (2) than other common mapping methods.
Authors: James W Shaw; A Simon Pickard; Shengsheng Yu; Shijie Chen; Vincent G Iannacchione; Jeffrey A Johnson; Stephen Joel Coons Journal: Value Health Date: 2009-12-04 Impact factor: 5.725
Authors: I-Chan Huang; Constantine Frangakis; Mark J Atkinson; Richard J Willke; Walter L Leite; W Bruce Vogel; Albert W Wu Journal: Health Serv Res Date: 2008-02 Impact factor: 3.402
Authors: Lina Holm Ingelsrud; J Mark Wilkinson; Soren Overgaard; Ola Rolfson; Brian Hallstrom; Ronald A Navarro; Michael Terner; Sunita Karmakar-Hore; Greg Webster; Luke Slawomirski; Adrian Sayers; Candan Kendir; Katherine de Bienassis; Niek Klazinga; Annette W Dahl; Eric Bohm Journal: Clin Orthop Relat Res Date: 2022-07-08 Impact factor: 4.755
Authors: Joanna Leaviss; Sarah Davis; Shijie Ren; Jean Hamilton; Alison Scope; Andrew Booth; Anthea Sutton; Glenys Parry; Marta Buszewicz; Rona Moss-Morris; Peter White Journal: Health Technol Assess Date: 2020-09 Impact factor: 4.014
Authors: Belinda J Gabbe; Emma McDermott; Pam M Simpson; Sarah Derrett; Shanthi Ameratunga; Suzanne Polinder; Ronan A Lyons; Frederick P Rivara; James E Harrison Journal: Popul Health Metr Date: 2015-06-13
Authors: Ola Rolfson; Eric Bohm; Patricia Franklin; Stephen Lyman; Geke Denissen; Jill Dawson; Jennifer Dunn; Kate Eresian Chenok; Michael Dunbar; Søren Overgaard; Göran Garellick; Anne Lübbeke Journal: Acta Orthop Date: 2016-05-26 Impact factor: 3.717
Authors: Ola Rolfson; Stephanie Wissig; Lisa van Maasakkers; Caleb Stowell; Ilana Ackerman; David Ayers; Thomas Barber; Thami Benzakour; Kevin Bozic; Nicolaas Budhiparama; James Caillouette; Philip G Conaghan; Leif Dahlberg; Jennifer Dunn; John Grady-Benson; Said A Ibrahim; Sally Lewis; Henrik Malchau; Mojieb Manzary; Lyn March; Nader Nassif; Rob Nelissen; Noel Smith; Patricia D Franklin Journal: Arthritis Care Res (Hoboken) Date: 2016-11 Impact factor: 4.794